Legitimacy Building under Weak Institutional Settings:Climate Change Adaptation at the Local Level in Denmark and Norway

In this article, we discuss local strategies for addressing the adaptation to climate change in Denmark and Norway. In both countries, the national impetus for local ad- aptation is weak. Thus, when it comes to the adaptation to climate change, it is largely left to local actors to take the initiative. The article seeks to shed light on the dynamics of the different approaches to climate change adaptation at the local level. Based on decision-making and learning theory, we present an analytical framework to examine four Scandinavian cases, two in Norway and two in Denmark, which represent two dif- ferent responses, i.e. anticipatory actions and obligatory actions to climate change adap- tation. Two of the municipalities – one in Norway and one in Denmark - are engaged in obligatory action in terms of addressing new climatic conditions and tend to use ex- isting standard operating procedures. The two other municipalities are engaging in an- ticipatory action. They are generally well aware of the adaptation issues and use innova- tive approaches to the new challenges. This research finds that, by bringing in knowledge and resources and engaging in persuasive communication across sectors, the presence of institutional entrepreneurs in the adaptation process plays a key role in building legitimacy for anticipatory action in the municipal organisation.Local strategies for adaptation to climate change in Denmark and Norway are discussed. In both countries, the national impetus for local adaptation is weak; it is largely left to local actors to take the initiative. The dynamics of the different approaches to climate-change adaptation at the local level are illuminated. Using decision-making and learning theory, we present an analytical framework to examine four cases, two in Norway and two in Denmark, which represent two different responses, i.e. anticipatory actions and obligatory actions. We find that, by bringing in knowledge and resources and engaging in persuasive communication across sectors, the presence of institutional entrepreneurs in the adaptation process plays a key role in building legitimacy for anticipatory action in the municipal organisation

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

The Khorana score is recommended for guiding primary venous thromboembolism (VTE) prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains debatable. Also, some previous validation studies have ignored the competing risk of death, hereby potentially overestimating VTE risk. We identified ambulatory cancer patients initiating chemotherapy without other indications for anticoagulation using Danish health registries and estimated 6-month cumulative incidence of VTE stratified by Khorana levels. Analyses were conducted with and without considering death as a competing risk using the Kaplan-Meier method vs the cumulative incidence function. Analyses were performed overall and stratified by cancer types. Of 40 218 patients, 35.4% were categorized by Khorana as low risk (score 0), 53.6% as intermediate risk (score 1 to 2), and 10.9% as high risk (score ≥3). Considering competing risk of death, the corresponding 6-month risks of VTE were 1.5% (95% confidence interval [CI], 1.3-1.7), 2.8% (95% CI, 2.6-3.1), and 4.1% (95% CI, 3.5-4.7), respectively. Among patients recommended anticoagulation by guidelines (Khorana score ≥2), the 6-month risk was 3.6% (95% CI, 3.3-3.9). Kaplan-Meier analysis overestimated incidence up to 23% compared with competing risk analyses. Using the guideline-recommended threshold of ≥2, the Khorana score did not risk-stratify patients with hepatobiliary or pancreatic cancer, lung cancer, and gynecologic cancer. In conclusion, the Khorana score was able to stratify ambulatory cancer patients according to the risk of VTE, but not for all cancer types. Absolute risks varied by methodology but were lower than in key randomized trials. Thus, although certain limitations with outcome identification using administrative registries apply, the absolute benefit of implementing routine primary thromboprophylaxis in an unselected cancer population may be smaller than seen in randomized trials

Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes

<p>Abstract</p> <p>Background</p> <p>Proteolytic degradation of Type I Collagen by proteases may play an important role in remodeling of atherosclerotic plaques, contributing to increased risk of plaque rupture.</p> <p>The aim of the current study was to investigate whether human macrophage foam cells degrade the extracellular matrix (ECM) of atherosclerotic plaques by cathepsin K mediated processes.</p> <p>Methods</p> <p>We 1) cultured human macrophages on ECM and measured cathepsin K generated fragments of type I collagen (C-terminal fragments of Type I collagen (CTX-I) 2) investigated the presence of CTX-I in human coronary arteries and 3) finally investigated the clinical potential by measuring circulating CTX-I in women with and without radiographic evidence of aortic calcified atherosclerosis.</p> <p>Results</p> <p>Immune-histochemistry of early and advanced lesions of coronary arteries demonstrated co-localization of Cathepsin-K and CTX-I in areas of intimal hyperplasia and in shoulder regions of advanced plaques. Treatment of human monocytes with M-CSF or M-CSF+LDL generated macrophages and foam cells producing CTX-I when cultured on type I collagen enriched matrix. Circulating levels of CTX-I were not significantly different in women with aortic calcifications compared to those without.</p> <p>Conclusions</p> <p>Human macrophage foam cells degrade the atherosclerotic plaques though cathepsin K mediated processes, resulting in increase in levels of CTX-I. Serum CTX-I was not elevated in women with aortic calcification, likely due to the contribution of CTX-I from osteoclastic bone resorption which involves Cathepsin-K. The human macrophage model system may be used to identify important pathway leading to excessive proteolytic plaque remodeling and plaque rupture.</p

Climate and environmental change drives Ixodes ricinus geographical expansion at the northern range margin

Background Global environmental change is causing spatial and temporal shifts in the distribution of species and the associated diseases of humans, domesticated animals and wildlife. In the on-going debate on the influence of climate change on vectors and vector-borne diseases, there is a lack of a comprehensive interdisciplinary multi-factorial approach utilizing high quality spatial and temporal data. Methods We explored biotic and abiotic factors associated with the latitudinal and altitudinal shifts in the distribution of Ixodes ricinus observed during the last three decades in Norway using antibodies against Anaplasma phagocytophilum in sheep as indicators for tick presence. Samples obtained from 2963 sheep from 90 farms in 3 ecologically different districts during 1978 – 2008 were analysed. We modelled the presence of antibodies against A. phagocytophilum to climatic-, environmental and demographic variables, and abundance of wild cervids and domestic animals, using mixed effect logistic regressions. Results Significant predictors were large diurnal fluctuations in ground surface temperature, spring precipitation, duration of snow cover, abundance of red deer and farm animals and bush encroachment/ecotones. The length of the growth season, mean temperature and the abundance of roe deer were not significant in the model. Conclusions Our results highlight the need to consider climatic variables year-round to disentangle important seasonal variation, climatic threshold changes, climate variability and to consider the broader environmental change, including abiotic and biotic factors. The results offer novel insight in how tick and tick-borne disease distribution might be modified by future climate and environmental change

Microplastics in Norwegian coastal areas, rivers, lakes and air (MIKRONOR1)

Prosjektleder Bert van BavelThe Norwegian Environment Agency (Miljødirektoratet, NEA) tasked the Norwegian Institute for Water Research (NIVA) to initiate Norway’s National microplastic monitoring program. The program “Microplastics in Norwegian coastal areas, rivers, lakes and air (MIKRONOR)”, was designed to target the multitude of environments in the Norwegian coastal, freshwater and terrestrial ecosystems. The primary aim is to provide information on levels and types of microplastics in aquatic environments as well as in air and build on the baseline data already generated for a number of these environments on previous assignments by NEA. This report contains the first results of coastal sites, open marine waters, lakes, rivers and air including high-volume water samples (freshwater and marine, n=48), Ferrybox samples (marine, n=20), blue mussels (marine, n=71), vertical plankton net samples (marine, n=29) and 24 air samples (precipitation n= 12 and active air sampling n = 12).Norwegian Environment AgencypublishedVersio

“Organ-in-a-Column” Coupled On-line with Liquid Chromatography-Mass Spectrometry

Organoids, i.e., laboratory-grown organ models developed from stem cells, are emerging tools for studying organ physiology, disease modeling, and drug development. On-line analysis of organoids with mass spectrometry would provide analytical versatility and automation. To achieve these features with robust hardware, we have loaded liquid chromatography column housings with induced pluripotent stem cell (iPSC) derived liver organoids and coupled the “organ-in-a-column” units on-line with liquid chromatography-mass spectrometry (LC-MS). Liver organoids were coloaded with glass beads to achieve an even distribution of organoids throughout the column while preventing clogging. The liver organoids were interrogated “on column” with heroin, followed by on-line monitoring of the drug’s phase 1 metabolism. Enzymatic metabolism of heroin produced in the “organ-in-a-column” units was detected and monitored using a triple quadrupole MS instrument, serving as a proof-of-concept for on-line coupling of liver organoids and mass spectrometry. Taken together, the technology allows direct integration of liver organoids with LC-MS, allowing selective and automated tracking of drug metabolism over time

“Organ-in-a-Column” Coupled On-line with Liquid Chromatography-Mass Spectrometry

Organoids, i.e., laboratory-grown organ models developed from stem cells, are emerging tools for studying organ physiology, disease modeling, and drug development. On-line analysis of organoids with mass spectrometry would provide analytical versatility and automation. To achieve these features with robust hardware, we have loaded liquid chromatography column housings with induced pluripotent stem cell (iPSC) derived liver organoids and coupled the “organ-in-a-column” units on-line with liquid chromatography-mass spectrometry (LC-MS). Liver organoids were coloaded with glass beads to achieve an even distribution of organoids throughout the column while preventing clogging. The liver organoids were interrogated “on column” with heroin, followed by on-line monitoring of the drug’s phase 1 metabolism. Enzymatic metabolism of heroin produced in the “organ-in-a-column” units was detected and monitored using a triple quadrupole MS instrument, serving as a proof-of-concept for on-line coupling of liver organoids and mass spectrometry. Taken together, the technology allows direct integration of liver organoids with LC-MS, allowing selective and automated tracking of drug metabolism over time